Abstract
The occurrence of transthyretin (TTR) in 25 endocrine pancreatic tumors was investigated by immunohistochemical methods using both polyclonal and monoclonal antibodies. All malignant insulinomas were strongly TTR immunoreactive, more so than their benign counterparts, which in some cases were TTR negative. All glucagonomas and nonfunctioning tumors were TTR immunoreactive, whereas gastrinomas and VIPomas were TTR negative. TTR, chromogranin A, and the argyrophil reaction (Grimelius' silver technique) had similar distributions among the cells in many, but not all, tumors. Coexistence of TTR with glucagon, insulin, or pancreatic polypeptide in tumor cells was demonstrated. TTR was also quantitated in preoperative serum samples by electroimmuno assay in some cases. Although one patient with a glucagonoma had a markedly increased serum TTR level, five other patients with endocrine tumors, including two patients with glucagonoma, had TTR levels in serum that were within or below the reference range.
Full text
PDF






Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aleshire S. L., Bradley C. A., Richardson L. D., Parl F. F. Localization of human prealbumin in choroid plexus epithelium. J Histochem Cytochem. 1983 May;31(5):608–612. doi: 10.1177/31.5.6341455. [DOI] [PubMed] [Google Scholar]
- Bussolati G., Papotti M., Sapino A. Binding of antibodies against human prealbumin to intestinal and bronchial carcinoids and to pancreatic endocrine tumours. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(1):15–22. doi: 10.1007/BF02889848. [DOI] [PubMed] [Google Scholar]
- Collins V. P., Jacobsson B., Pettersson T., Carlström A. Monoclonal antibodies to transthyretin. Scand J Clin Lab Invest. 1986 Dec;46(8):761–769. doi: 10.3109/00365518609084048. [DOI] [PubMed] [Google Scholar]
- Grimelius L., Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol. 1980 Jan-Mar;3(1):3–12. [PubMed] [Google Scholar]
- Harris R. I., Kohn J. The pre-albumin fraction: a useful parameter in the interpretation of routine protein electrophoresis. J Clin Pathol. 1974 Dec;27(12):986–989. doi: 10.1136/jcp.27.12.986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herbert J., Wilcox J. N., Pham K. T., Fremeau R. T., Jr, Zeviani M., Dwork A., Soprano D. R., Makover A., Goodman D. S., Zimmerman E. A. Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology. 1986 Jul;36(7):900–911. doi: 10.1212/wnl.36.7.900. [DOI] [PubMed] [Google Scholar]
- Kameko M., Ichikawa M., Katsuyama T., Kanai M., Kato M., Akamatsu T. Immunohistochemical localization of plasma retinol-binding protein and prealbumin in human pancreatic islets. Histochem J. 1986 Apr;18(4):164–168. doi: 10.1007/BF01676116. [DOI] [PubMed] [Google Scholar]
- Kruseman A. C., Knijnenburg G., de la Riviere G. B., Bosman F. T. Morphology and immunohistochemically-defined endocrine function of pancreatic islet cell tumours. Histopathology. 1978 Nov;2(6):389–399. doi: 10.1111/j.1365-2559.1978.tb01733.x. [DOI] [PubMed] [Google Scholar]
- Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
- Liddle C. N., Reid W. A., Kennedy J. S., Miller I. D., Horne C. H. Immunolocalization of prealbumin: distribution in normal human tissue. J Pathol. 1985 Jun;146(2):107–113. doi: 10.1002/path.1711460205. [DOI] [PubMed] [Google Scholar]
- Miller I. D., Reid W. A., Liddle C. N., Horne C. H. Immunolocalization of prealbumin as a marker for carcinoid tumours. J Pathol. 1984 Jul;143(3):199–204. doi: 10.1002/path.1711430308. [DOI] [PubMed] [Google Scholar]
- Rajatanavin R., Liberman C., Lawrence G. D., D'Arcangues C. M., Young R. A., Emerson C. H. Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma. J Clin Endocrinol Metab. 1985 Jul;61(1):17–21. doi: 10.1210/jcem-61-1-17. [DOI] [PubMed] [Google Scholar]
- Rindi G., Buffa R., Sessa F., Tortora O., Solcia E. Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with the argyrophil component of secretory granules. Histochemistry. 1986;85(1):19–28. doi: 10.1007/BF00508649. [DOI] [PubMed] [Google Scholar]
- Robbins J., Cheng S. Y., Gershengorn M. C., Glinoer D., Cahnmann H. J., Edelnoch H. Thyroxine transport proteins of plasma. Molecular properties and biosynthesis. Recent Prog Horm Res. 1978;34:477–519. doi: 10.1016/b978-0-12-571134-0.50017-x. [DOI] [PubMed] [Google Scholar]
- Rondana M., Milani L., Merkel C., Caregaro L., Gatta A. Value of prealbumin plasma levels as liver test. Digestion. 1987;37(2):72–78. doi: 10.1159/000199471. [DOI] [PubMed] [Google Scholar]
- Tapia F. J., Polak J. M., Barbosa A. J., Bloom S. R., Marangos P. J., Dermody C., Pearse A. G. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet. 1981 Apr 11;1(8224):808–811. doi: 10.1016/s0140-6736(81)92682-9. [DOI] [PubMed] [Google Scholar]
- Wilson B. S., Lloyd R. V. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol. 1984 Jun;115(3):458–468. [PMC free article] [PubMed] [Google Scholar]



